tweetup-jacek-nov2016-ok-mas-oscurook

Access to Medicines: join us in the debate!

The role of generic, biosimilar and value added medicines in increasing access to innovative treatment

CONNECT BY USING THE HASHTAG
#ASKJACEKGLINKA

Access to medicines and security of supply should be central… 13 June 2023 Generic and biosimilar medicines significantly lower healthcare treatment costs and…
"Off patent medicines essential for a fairer, healthier, and… 30 April 2021 Christoph Stoller will speak at 3A CONFERENCE - Availability, Accessibility,…
Smart reform of EU pharma and IP legislation key to boosting… 28 June 2022 Generic and biosimilar medicines lower healthcare treatment costs dramatically and…
Time for the EU to take steps: a medicines security act is… 2 October 2023 The off-patent medicines industry provides 70% of medicines dispensed to…